查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1570685

AAV 包装服务市场：按应用程式、最终用户、向量类型、製造方法、组件分类 - 2025-2030 年全球预测

AAV Packaging Service Market by Application, End User (Academic Institutions, Biopharmaceutical Companies, Contract Research Organizations ), Vector Type, Production Method, Component - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年 AAV 包装服务市值为 17.2 亿美元，预计到 2024 年将达到 18.4 亿美元，复合年增长率为 5.39%，预计到 2030 年将达到 24.9 亿美元。

AAV（腺结合病毒）包装服务市场是基因治疗开发的核心，主要促进遗传物质向宿主细胞的传递。该服务定义了将 DNA 安全有效地包装到 AAV 载体中，已知 AAV 载体是非致病性的，并表现出广泛的组织向性。对 AAV 包装服务的需求是由用于治疗遗传和罕见疾病的基因疗法的扩展所推动的。应用涵盖肿瘤学、神经病学和心臟病学等医学领域，最终用途为製药公司、研究机构和临床实验室。市场成长受到 CRISPR 技术进步、研发投资增加以及孤儿药监管激励等因素的影响。遗传疾病的日益普及进一步推动了需求。然而，市场面临生产高成本、监管环境严格以及影响供需不匹配的可扩展性问题等挑战。机会存在于改进载体设计以实现高效基因转移、探索合成生物学以获得更好的有效负载能力以及增强可扩展的製造过程。建议投资生物资讯学和人工智慧以实现精确的载体定制，以保持领先地位。新兴国家对具有成本效益的基因治疗解决方案的需求不断增长。与学术界和生物技术公司的合作可以加速创新和市场渗透。然而，存在需要进一步调查和伦理考虑的局限性，例如知识产权的复杂性和脱靶效应的可能性。随着研究和技术的不断发展，AAV 包装服务市场呈现出充足的创新空间，特别是在开发具有更高特异性和更低免疫抗原性的下一代载体方面。总体而言，策略重点是克服生产挑战和有效应对法律规范可以实现显着的业务成长，相关人员将从这个快速成长的细分市场中受益，并保持优势地位。

主要市场统计
基准年[2023] 17.2亿美元
预测年份 [2024] 18.4亿美元
预测年份 [2030] 24.9亿美元
复合年增长率（%） 5.39%

市场动态：揭示快速发展的 AAV 包装服务市场的关键市场洞察

AAV 包装服务市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助组织降低政治、地理、技术、社会和经济领域的风险，以及消费行为及其对製造成本的影响，还可以更清楚地了解其对采购趋势的影响。

波特五力：驾驭 AAV 包装服务市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解 AAV 包装服务市场的外部影响

外部宏观环境因素在塑造 AAV 包装服务市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 AAV 包装服务市场的竞争格局

对 AAV 包装服务市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 AAV 包装服务市场供应商的绩效评估

FPNV 定位矩阵是评估 AAV 包装服务市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了 AAV 包装服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对 AAV 包装服务市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告提供了涵盖关键焦点细分市场的全面市场分析。

1. 市场渗透率：对当前市场环境的详细回顾。

2. 市场开拓：辨识新兴市场的成长机会，评估现有产业的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检视市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 基因治疗研究的进展增加了对 AAV 包装服务的需求
      • 越来越多的遗传疾病需要有效的基因传递解决方案
      • 製药公司加大基因治疗的投资
      • 增加政府对基因研究和开发的支持和资助
    • 抑制因素
      • AAV 包装服务缺乏标准化通讯协定限制了市场扩张
      • 智慧财产权问题和专利纠纷正在阻碍AAV包装服务的进展
    • 机会
      • 为製药公司提供可扩展的 AAV 包装解决方案以进行药物开发
      • 与学术机构合作进行 AAV 载体设计与应用的创新研究
      • 优化 AAV 包装通讯协定以提高产量和品管标准
    • 任务
      • 解决 AAV 包装服务产业的高成本和投资要求，实现可扩展生产
      • 满足日益增长的个人化 AAV 包装服务需求，以满足特定治疗需求
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 AAV 包装服务市场：依应用分类

  • 介绍
  • 心臟病学
  • 细胞疗法
    • CAR-T疗法
    • 干细胞疗法
  • 基因治疗
    • 单基因疾病
    • 多基因疾病
  • 神经病学
  • 肿瘤学
  • 眼科
  • 疫苗学
    • 癌症疫苗
    • 感染疾病

第 7 章 AAV 包装服务市场：依最终用户分类

  • 介绍
  • 学术机构
  • 生物製药公司
  • 合约研究组织（CRO）
  • 研究所

第 8 章 AAV 包装服务市场：按向量类型

  • 介绍
  • 腺结合病毒1 (AAV1)
  • 腺结合病毒2 (AAV2)
  • 腺结合病毒5 (AAV5)
  • 腺结合病毒6 (AAV6)
  • 腺结合病毒8 (AAV8)
  • 腺结合病毒9 (AAV9)

第九章 AAV 包装服务市场：依製造方法分类

  • 介绍
  • 桿状病毒/Sf9系统
  • 细胞株包装
  • 瞬时转染

第 10 章 AAV 包装服务市场：按组成部分

  • 介绍
  • 反向末端重复序列 (ITR)
  • 发起人
  • 基因改造
  • 向量衣壳

第十一章美洲AAV包装服务市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区 AAV 包装服务市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲AAV包装服务市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-546E6FBB35F6

The AAV Packaging Service Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.84 billion in 2024, and is projected to grow at a CAGR of 5.39%, to USD 2.49 billion by 2030.

The AAV (Adeno-Associated Virus) Packaging Service market is at the heart of gene therapy development, primarily facilitating the delivery of genetic material into host cells. This service defines the safe and efficient packaging of DNA into AAV vectors, which are known for being non-pathogenic and exhibiting broad tissue tropism. The necessity for AAV packaging services is driven by the expanding gene therapy landscape, aimed at treating genetic and rare diseases. Applications extend across healthcare domains including oncology, neurology, and cardiology, with end-use spanning pharmaceutical companies, research institutions, and clinical labs. Market growth is influenced by factors such as advancements in CRISPR technology, increasing R&D investments, and regulatory incentives for orphan drugs. The growing prevalence of genetic disorders further fuels demand. However, the market faces challenges like high costs associated with production, stringent regulatory landscapes, and scalability issues impacting supply and demand mismatches. Opportunities lie in improving vector designs for efficient gene delivery, exploring synthetic biology for better payload capacity, and enhancing scalable manufacturing processes. Investing in bioinformatics and AI for precise vector customization is recommended to stay ahead. Regional market shifts present openings in emerging economies, where the demand for cost-effective gene therapy solutions is rising. Collaborations with academia and biotech firms can accelerate innovation and market penetration. Limitations still include IP complexities and potential off-target effects, necessitating further research and ethical considerations. As research and technological advances continue to evolve, the AAV Packaging Service market presents ample room for innovation, particularly in developing next-generation vectors with enhanced specificity and reduced immunogenicity. Overall, a strategic focus on overcoming production challenges and navigating regulatory frameworks efficiently can unlock substantial business growth, keeping stakeholders well-positioned in this burgeoning field.

KEY MARKET STATISTICS
Base Year [2023] USD 1.72 billion
Estimated Year [2024] USD 1.84 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 5.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving AAV Packaging Service Market

The AAV Packaging Service Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Advancements in gene therapy research driving demand for AAV packaging services
    • Rising prevalence of genetic disorders necessitating efficient gene delivery solutions
    • Increasing investment from pharmaceutical companies in gene therapy initiatives
    • Growing governmental support and funding for genetic research and development
  • Market Restraints
    • Lack of standardized protocols in AAV packaging services limiting market expansion
    • Intellectual property issues and patent disputes hindering advancements in AAV packaging services
  • Market Opportunities
    • Targeting pharmaceutical companies with scalable AAV packaging solutions for drug development
    • Partnering with academic institutions for innovative research in AAV vector design and application
    • Optimizing AAV packaging protocols to improve production yield and quality control standards
  • Market Challenges
    • Addressing the high costs and investment requirements in the AAV packaging service industry for scalable production
    • Meeting the increasing demand for personalized AAV packaging services to cater to specific therapeutic needs

Porter's Five Forces: A Strategic Tool for Navigating the AAV Packaging Service Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the AAV Packaging Service Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the AAV Packaging Service Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the AAV Packaging Service Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the AAV Packaging Service Market

A detailed market share analysis in the AAV Packaging Service Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the AAV Packaging Service Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the AAV Packaging Service Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the AAV Packaging Service Market

A strategic analysis of the AAV Packaging Service Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the AAV Packaging Service Market, highlighting leading vendors and their innovative profiles. These include 4D Molecular Therapeutics, Adverum Biotechnologies, Asklepios BioPharmaceutical, Audentes Therapeutics, Baylor College of Medicine, Biogen, Brammer Bio, Dimension Therapeutics, Freeline Therapeutics, Genethon, Lonza, Oxford Biomedica, REGENXBIO, SIRION Biotech, Spark Therapeutics, Thermo Fisher Scientific, Vigene Biosciences, Virovek, Voyager Therapeutics, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the AAV Packaging Service Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Cardiology, Cell Therapy, Gene Therapy, Neurology, Oncology, Ophthalmology, and Vaccinology. The Cell Therapy is further studied across CAR-T Therapy and Stem Cell Therapy. The Gene Therapy is further studied across Monogenic Disorders and Multigenic Disorders. The Vaccinology is further studied across Cancer Vaccines and Infectious Diseases.
  • Based on End User, market is studied across Academic Institutions, Biopharmaceutical Companies, Contract Research Organizations (CROs), and Research Institutes.
  • Based on Vector Type, market is studied across Adeno-Associated Virus 1 (AAV1), Adeno-Associated Virus 2 (AAV2), Adeno-Associated Virus 5 (AAV5), Adeno-Associated Virus 6 (AAV6), Adeno-Associated Virus 8 (AAV8), and Adeno-Associated Virus 9 (AAV9).
  • Based on Production Method, market is studied across Baculovirus/Sf9 System, Packaging Cell Lines, and Transient Transfection.
  • Based on Component, market is studied across Inverted Terminal Repeats (ITRs), Promoters, Transgene, and Vector Capsid.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Advancements in gene therapy research driving demand for AAV packaging services
      • 5.1.1.2. Rising prevalence of genetic disorders necessitating efficient gene delivery solutions
      • 5.1.1.3. Increasing investment from pharmaceutical companies in gene therapy initiatives
      • 5.1.1.4. Growing governmental support and funding for genetic research and development
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standardized protocols in AAV packaging services limiting market expansion
      • 5.1.2.2. Intellectual property issues and patent disputes hindering advancements in AAV packaging services
    • 5.1.3. Opportunities
      • 5.1.3.1. Targeting pharmaceutical companies with scalable AAV packaging solutions for drug development
      • 5.1.3.2. Partnering with academic institutions for innovative research in AAV vector design and application
      • 5.1.3.3. Optimizing AAV packaging protocols to improve production yield and quality control standards
    • 5.1.4. Challenges
      • 5.1.4.1. Addressing the high costs and investment requirements in the AAV packaging service industry for scalable production
      • 5.1.4.2. Meeting the increasing demand for personalized AAV packaging services to cater to specific therapeutic needs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. AAV Packaging Service Market, by Application

  • 6.1. Introduction
  • 6.2. Cardiology
  • 6.3. Cell Therapy
    • 6.3.1. CAR-T Therapy
    • 6.3.2. Stem Cell Therapy
  • 6.4. Gene Therapy
    • 6.4.1. Monogenic Disorders
    • 6.4.2. Multigenic Disorders
  • 6.5. Neurology
  • 6.6. Oncology
  • 6.7. Ophthalmology
  • 6.8. Vaccinology
    • 6.8.1. Cancer Vaccines
    • 6.8.2. Infectious Diseases

7. AAV Packaging Service Market, by End User

  • 7.1. Introduction
  • 7.2. Academic Institutions
  • 7.3. Biopharmaceutical Companies
  • 7.4. Contract Research Organizations (CROs)
  • 7.5. Research Institutes

8. AAV Packaging Service Market, by Vector Type

  • 8.1. Introduction
  • 8.2. Adeno-Associated Virus 1 (AAV1)
  • 8.3. Adeno-Associated Virus 2 (AAV2)
  • 8.4. Adeno-Associated Virus 5 (AAV5)
  • 8.5. Adeno-Associated Virus 6 (AAV6)
  • 8.6. Adeno-Associated Virus 8 (AAV8)
  • 8.7. Adeno-Associated Virus 9 (AAV9)

9. AAV Packaging Service Market, by Production Method

  • 9.1. Introduction
  • 9.2. Baculovirus/Sf9 System
  • 9.3. Packaging Cell Lines
  • 9.4. Transient Transfection

10. AAV Packaging Service Market, by Component

  • 10.1. Introduction
  • 10.2. Inverted Terminal Repeats (ITRs)
  • 10.3. Promoters
  • 10.4. Transgene
  • 10.5. Vector Capsid

11. Americas AAV Packaging Service Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific AAV Packaging Service Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa AAV Packaging Service Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 4D Molecular Therapeutics
  • 2. Adverum Biotechnologies
  • 3. Asklepios BioPharmaceutical
  • 4. Audentes Therapeutics
  • 5. Baylor College of Medicine
  • 6. Biogen
  • 7. Brammer Bio
  • 8. Dimension Therapeutics
  • 9. Freeline Therapeutics
  • 10. Genethon
  • 11. Lonza
  • 12. Oxford Biomedica
  • 13. REGENXBIO
  • 14. SIRION Biotech
  • 15. Spark Therapeutics
  • 16. Thermo Fisher Scientific
  • 17. Vigene Biosciences
  • 18. Virovek
  • 19. Voyager Therapeutics
  • 20. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. AAV PACKAGING SERVICE MARKET RESEARCH PROCESS
  • FIGURE 2. AAV PACKAGING SERVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. AAV PACKAGING SERVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. AAV PACKAGING SERVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AAV PACKAGING SERVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AAV PACKAGING SERVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY MONOGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY MULTIGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 1 (AAV1), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 2 (AAV2), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 5 (AAV5), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 6 (AAV6), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 8 (AAV8), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 9 (AAV9), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY BACULOVIRUS/SF9 SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PACKAGING CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY TRANSIENT TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY INVERTED TERMINAL REPEATS (ITRS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY TRANSGENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR CAPSID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 328. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 336. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN AAV PACKAGING SER